![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, December 16, 2023 6:02:17 PM
As far as CMML, I think the data I linked in my previous post indicated that current Standard of Care yields a Complete Response rate ranging from 16-21%. I also think that the interim analysis of the PREACH-M study showed a Complete Response rate of 73%. The P-value was 0.02. This reflects my understanding of the data I linked earlier.
I think that level of improvement, complete with establishing biomarkers where there were none, justifies Dr. Thomas' excitement, as well as approval and regulatory incentives, including a PRV, from the Australian regulators.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM